For non-SRCCs, some authors favored an association between MMR loss and higher PD-L1 expression rates in tumor cells, but it is still difficult to understand the frequency and significance of MMR deficiency in PD-L1-positive and -negative groups [24,25,26]. This evidence concerns the gene CD274 and mismatch repair cancer syndrome 1.